PHGE BiomX Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: PHGE

Price (delayed)

$0.382

Market cap

$21.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.51

Enterprise value

$20.32M

BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria ...

Highlights
PHGE's EPS is up by 46% year-on-year and by 22% since the previous quarter
BiomX's debt has decreased by 22% YoY and by 7% from the previous quarter
The equity has shrunk by 85% YoY and by 62% QoQ
The quick ratio has dropped by 67% year-on-year and by 22% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.biomx.com
Peers: OMER OMGA

Key stats

What are the main financial stats of PHGE
Market
Shares outstanding
55.22M
Market cap
$21.09M
Enterprise value
$20.32M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.7
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$23.74M
EBITDA
-$22.87M
Free cash flow
-$21.34M
Per share
EPS
-$0.51
Free cash flow per share
-$0.42
Book value per share
$0.07
Revenue per share
$0
TBVPS
$0.49
Balance sheet
Total assets
$25.03M
Total liabilities
$21.95M
Debt
$15.09M
Equity
$3.08M
Working capital
$6.46M
Liquidity
Debt to equity
4.9
Current ratio
1.58
Quick ratio
1.42
Net debt/EBITDA
0.03
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-74.4%
Return on equity
-242%
Return on invested capital
-152.3%
Return on capital employed
-171.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PHGE stock price

How has the BiomX stock price performed over time
Intraday
-6.83%
1 week
9.14%
1 month
9.14%
1 year
41.48%
YTD
36.43%
QTD
-15.11%

Financial performance

How have BiomX's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.35M
Net income
-$26.17M
Gross margin
N/A
Net margin
N/A
BiomX's net income has increased by 8% YoY
PHGE's operating income is up by 7% YoY

Growth

What is BiomX's growth rate over time

Valuation

What is BiomX stock price valuation
P/E
N/A
P/B
5.7
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PHGE's EPS is up by 46% year-on-year and by 22% since the previous quarter
The stock's P/B is 85% above its 5-year quarterly average of 3.3
The equity has shrunk by 85% YoY and by 62% QoQ

Efficiency

How efficient is BiomX business performance
The ROE has dropped by 157% year-on-year and by 39% since the previous quarter
PHGE's return on invested capital has dropped by 65% year-on-year and by 17% since the previous quarter
The ROA has contracted by 48% YoY and by 13% from the previous quarter

Dividends

What is PHGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PHGE.

Financial health

How did BiomX financials performed over time
The total assets is 14% greater than the total liabilities
The quick ratio has dropped by 67% year-on-year and by 22% since the previous quarter
BiomX's current ratio has shrunk by 66% YoY and by 20% QoQ
The company's debt to equity has surged by 146% QoQ
The equity has shrunk by 85% YoY and by 62% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.